Key Highlights

  • Datavault AI reported Q2 2026 Revenue of $6.7 million, up 287% year-over-year, but first-half revenue of $10.1 million was only about 5% of its reiterated $200 million full-year 2026 target.
  • Iveda Solutions reported first-half 2026 revenue of about $2.3 million, down from $3.0 million a year earlier, with three Taiwan customers accounting for 72% of revenue.
  • Datavault reported a six-month net loss of $141.2 million and disclosed it missed its initial Nasdaq bid-price compliance deadline, receiving an extension to February 22, 2027.
  • Iveda received a second 180-day Nasdaq compliance extension to March 1, 2027, while expanding into Europe through a Partnership with Primion and reporting disclosure controls were not effective.

For AI microcaps, the real test is whether paying customers show up, renew and expand. Datavault AI (NASDAQ:DVLT) and Iveda Solutions (NASDAQ:IVDA) both trade on the Nasdaq Capital Market and both call themselves AI businesses, but the resemblance ends there. One is chasing a very large revenue target built on licensing, tokenization and data exchanges; the other sells AI video analytics and sensors with revenue in the low millions.

Datavault AI (NASDAQ:DVLT): A Large Target Resting on a Small Base

Datavault AI is the former WiSA Technologies, a wireless audio company that adopted its current name in February 2025. The Business now spans acoustic technology, data science licensing, tokenization of real-world Assets and a set of data exchanges. In an August 19, 2026 release, the company reported second-quarter 2026 revenue of $6.7 million, up 287% from $1.7 million a year earlier, and first-half revenue of $10.1 million versus $2.4 million in the first half of 2025. The net loss for the six months was $141.2 million, compared with $46.7 million a year earlier.

At June 30, 2026, Datavault reported cash and equivalents of $1.4 million, crypto assets of $49.0 million and total assets of $276.6 million. Shares outstanding rose to 854.5 million from 573.4 million at the end of 2025. Management reiterated a full-year 2026 revenue target of at least $200 million, saying the target implies a bump in the third quarter and "a very significant bump in Q4," citing tokenization contracts, licensing deals and planned exchange launches, including the acquired NYIAX.

There are also governance and listing matters. An August 25, 2026 Form 8-K disclosed that Datavault missed its initial deadline to regain compliance with Nasdaq's $1.00 minimum bid price rule and received an extension to February 22, 2027, noting it may effect a reverse split if necessary. In September 2026, a securities class action was filed alleging misleading statements during a 2024 to 2025 class period; those are allegations and have not been proven.

Iveda Solutions (NASDAQ:IVDA): Steady Margins, Concentrated Demand

Iveda Solutions provides cloud-based AI video analytics, IoT sensors and smart-city products for public safety and security customers. Its 10-Q for the six months ended June 30, 2026 showed revenue of about $2.3 million, down from roughly $3.0 million a year earlier, while Gross Profit rose to about $934,000, a Margin near 41%. The net loss was about $1.3 million, roughly flat year over year, and cash stood at about $4.8 million. Management stated that cash would be sufficient to fund its operating plan for at least twelve months.

Customer concentration stands out: three Taiwan customers accounted for 72% of first-half revenue, with one, National Chung Shan Institute, at 41%. The company also reported that its disclosure controls were not effective as of June 30, 2026.

Iveda has been working to broaden that base. In July 2026 it announced a partnership making its IvedaAI platform available through Primion, a European converged-security provider, and in August it described EU AI Act readiness work alongside a new operations center in Spain. It also announced a GlobalMed partnership aimed at government agencies and launched IvedaAir unmanned aircraft products. On September 9, 2026, Iveda said Nasdaq had granted a second 180-day period, to March 1, 2027, to meet the minimum bid price requirement.

Why Customer Adoption Matters

Announcements are plentiful at both companies. What separates a promising AI product from a durable business is converting partnerships into recurring, diversified revenue. Datavault's challenge is scale: its first-half revenue was about 5% of its full-year target, so the gap between signed agreements and recognized revenue is the key variable. Iveda's challenge is breadth: its revenue is real and its margins improved, but a small number of Taiwan customers drive most of it.

  • Revenue versus targets: Does Datavault's third-quarter revenue show the step-up management described?
  • Customer diversification: Does Iveda's share of revenue from its top three customers fall as Primion and GlobalMed channels develop?
  • Cash conversion: How much of each company's revenue turns into operating cash rather than receivables or non-cash assets?
  • Share count: How fast is the share base growing relative to revenue?

Using the Nasdaq Composite as a Benchmark

The Nasdaq Composite, heavily weighted toward large technology companies, helps separate sector-wide moves from company-specific ones. A microcap that diverges sharply from it is likely reacting to its own news, financings or listing issues. The index is used here only as a comparison benchmark, not as a claim that either company is a constituent.

Small caps typically swing more sharply than broad indexes and are more exposed to dilution, reverse splits and delisting risk.

Risks

Datavault's risks center on execution and structure: a revenue target that depends heavily on the fourth quarter, a cash balance of $1.4 million alongside $49.0 million in crypto assets whose value can fluctuate, a share count that rose by roughly half in six months, a Nasdaq bid-price deadline in February 2027 and pending litigation.

Iveda's risks are narrower but still material. Revenue fell 24% in the first half, a few Taiwan customers dominate sales, internal controls were reported as not effective, and the company faces its own bid-price deadline in March 2027.

Reported Revenue and Customer Mix Will Speak Louder Than Headlines

Datavault AI and Iveda Solutions are two very different AI microcaps. Datavault offers a large stated ambition, a growing but still small revenue base and significant balance-sheet and governance complexity. Iveda offers a modest, higher-margin business that is trying to expand beyond a handful of concentrated customers. In both cases, reported revenue, customer mix and Cash Flow in upcoming filings will matter more than company headlines.